Timothy P. Walbert - 01 Nov 2021 Form 4 Insider Report for Horizon Therapeutics Public Ltd Co

Signature
/s/ Miles W. McHugh, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
01 Nov 2021
Net transactions value
-$2,962,327
Form type
4
Filing time
03 Nov 2021, 16:30:57 UTC
Previous filing
01 Oct 2021
Next filing
01 Dec 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HZNP Ordinary Shares Gift $0 -100,300 -76% $0.000000 31,196 26 Oct 2021 By spouse
transaction HZNP Ordinary Shares Gift $0 +100,300 $0.000000 100,300 26 Oct 2021 See footnote F1
transaction HZNP Ordinary Shares Sale $915,135 -7,801 -1.3% $117.31 571,681 01 Nov 2021 Direct F2, F3
transaction HZNP Ordinary Shares Sale $808,963 -6,829 -1.2% $118.46 564,852 01 Nov 2021 Direct F2, F4
transaction HZNP Ordinary Shares Sale $1,161,731 -9,733 -1.7% $119.36 555,119 01 Nov 2021 Direct F2, F5
transaction HZNP Ordinary Shares Sale $76,497 -637 -0.11% $120.09 554,482 01 Nov 2021 Direct F2, F6
holding HZNP Ordinary Shares 107,739 01 Nov 2021 See footnote F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares are held by the Keli B. Walbert 2021 Gift Trust, of which the Reporting Person is the Trustee. The beneficiaries of the Trust include the Reporting Person and his descendants.
F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2021.
F3 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.96 to $117.95 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.99 to $118.98 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $118.985 to $119.97 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F6 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $119.99 to $120.32 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F7 The shares are held by the Timothy P. Walbert 2021 Gift Trust, of which the Reporting Person's spouse is the Trustee and beneficiary.